Interestingly, CLSPN knockdown inhibited apoptosis and increased cell survival in UROtsa cells (benign), while CLSPN knockdown enhanced apoptosis and decreased cell survival in 5637 cells (urothelial carcinoma). Here, CLSPN is linked to urothelial carcinoma.